TNFRSF11B and osteoporosis: IL-6 can also promote osteoclastic activity and bone loss by activating the osteoprotegerin/receptor activator of nuclear factor kappa B ligand/receptor activator of the nuclear factor kappa B (OPG/RANKL/RANK) system, leading to osteoporosis [23].